
CL · NYSE
Colgate-Palmolive is a branded consumer-products company selling oral-care products, personal-care products, home-care products and Hill’s pet nutrition. It makes money by selling these products to consumers through retail and other distribution channels, with oral care as its flagship category and the other businesses providing additional revenue streams; the supplied evidence does not provide individual segment contributions. Its customers include households, retailers and pet owners. The company reported $20.4 billion of FY2025 revenue and $2.1 billion of net income, compared with $20.1 billion and $2.9 billion, respectively, in FY2024.
Colgate-Palmolive fell $0.20, or 0.22%, from $92.73 to $92.53 over the week. The main catalyst was its second-quarter report, which beat earnings and revenue estimates, delivered 4.9% sales growth, and showed broad-based organic sales, productivity gains and gross-margin expansion. Those positives were tempered by a year-over-year profit decline and higher brand investment, while the stock also responded to the company’s confirmation of its FY2026 outlook and higher Base Business earnings-per-share view. The shares rose to $93.49 on Wednesday before giving back the gain on Thursday and Friday, then dropped to $89.88 Monday before rebounding sharply Tuesday. The supplied evidence does not identify a separate market-wide driver.